Detalles de la búsqueda
1.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat;
202(3): 485-496, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676450
2.
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol;
35(10): 1362-1369, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35729220
3.
Case-based survey: The impact of breast-cancer treatment on fertility in Japan.
J Obstet Gynaecol Res;
48(3): 553-562, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933405
4.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol;
22(1): 74-84, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387497
5.
Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity.
Cancer Immunol Immunother;
70(3): 817-830, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33000417
6.
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer.
BMC Cancer;
21(1): 239, 2021 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676425
7.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol;
250(5): 667-684, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129476
8.
Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study.
BMC Cancer;
20(1): 67, 2020 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31996163
9.
Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy.
World J Surg Oncol;
18(1): 177, 2020 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32693794
10.
Nationwide survey of Japanese breast oncology and reproductive endocrinology departments about the impact of breast cancer treatment on fertility.
J Obstet Gynaecol Res;
2020 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063425
11.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology;
75(2): 225-235, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31017314
12.
[Locally Advanced Breast Cancer Treated with Mohs' Paste and Neoadjuvant Chemotherapy-A Case Report].
Gan To Kagaku Ryoho;
46(13): 2131-2133, 2019 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-32156855
13.
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.
Cancer Sci;
109(3): 587-599, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29288540
14.
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer.
Breast Cancer Res Treat;
169(3): 437-446, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423901
15.
[Current Status and Future Perspectives of the Navigation Surgery in Breast Cancer - The Clinical Utility of Sentinel Lymph Node Biopsy Using ICG].
Gan To Kagaku Ryoho;
45(8): 1139-1143, 2018 08.
Artículo
en Japonés
| MEDLINE | ID: mdl-30158405
16.
Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis.
Int J Clin Oncol;
22(1): 11-17, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864624
17.
Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.
Ann Surg Oncol;
23(1): 44-50, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275781
18.
[The Clinical Utility of Pegfilgrastim in Combination with Adjuvant FEC(100)and TC Chemotherapy for Breast Cancer].
Gan To Kagaku Ryoho;
43(9): 1087-90, 2016 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-27628549
19.
Personalization of loco-regional care for primary breast cancer patients (part 1).
Future Oncol;
11(9): 1297-300, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25952777
20.
Personalization of loco-regional care for primary breast cancer patients (part 2).
Future Oncol;
11(9): 1301-5, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25952778